{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T11:31:56Z","timestamp":1764502316703,"version":"3.46.0"},"reference-count":16,"publisher":"Practical Medicine Publishing House","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Oncohematology"],"abstract":"<jats:p>Background &amp; Aims.\u00a0Most children with Hodgkin\u2019s lymphoma (HL) can be cured irrespective of the disease stage using modern risk adapted protocols. But 3\u20135\u00a0% of children develop relapse of the disease or refractoriness to the treatment performed. The aim of the study was to perform a comparative analysis of ViGePP vs ICE antitumor treatment regimens in patients with relapsed and refractory Hodgkin\u2019s lymphoma, as well as to evaluate the need in auto-HSCT and the site for a combined chemoradiation therapy in this patient population.\r\nMethods.\u00a0From June, 2003, till December, 2014, 35 patients with relapsed (18) and refractory (17) HL received chemotherapy based on two regimes: ICE (n\u00a0=\u00a014; 40\u00a0%) and ViGePP (n\u00a0=\u00a014; 40\u00a0%). 7 (20\u00a0%) children were switched to another regimen due to a poor antitumor response to the first two courses of chemotherapy.\r\nResults.\u00a0The direct effectiveness of the therapy was significantly higher in patients on ViGePP as compared to ICE irrespective of the disease status (relapsed or refractory). A complete response was achieved more often in those children with relapse HL whose initial treatment included radiation therapy. Higher survival rates were registered in girls, as well as in children with a complete overall response to the antirelapse therapy. In case of relapses, delayed treatment effects (disease free survival and overall survival) were higher in children treated with 4 courses of ViGePP than 2 courses of ICE. High-dose chemotherapy with subsequent auto-HSCT is not able to overcome refractoriness to the chemotherapy.\r\nConclusion.\u00a0Children with relapsed and refractory HL need an intensive antirelapse chemotherapy with subsequent HDC and auto-HSCT to achieve CR.<\/jats:p>","DOI":"10.21320\/2500-2139-2016-9-1-13-21","type":"journal-article","created":{"date-parts":[[2016,5,21]],"date-time":"2016-05-21T20:09:49Z","timestamp":1463861389000},"page":"13-21","source":"Crossref","is-referenced-by-count":0,"title":["Treatment of Relapsed and Refractory Hodgkin\u2019s Lymphoma in Children","\u041b\u0435\u0447\u0435\u043d\u0438\u0435 \u0440\u0435\u0446\u0438\u0434\u0438\u0432\u043e\u0432 \u0438 \u0440\u0435\u0444\u0440\u0430\u043a\u0442\u0435\u0440\u043d\u044b\u0445 \u0444\u043e\u0440\u043c \u043b\u0438\u043c\u0444\u043e\u043c\u044b \u0425\u043e\u0434\u0436\u043a\u0438\u043d\u0430 \u0443 \u0434\u0435\u0442\u0435\u0439"],"prefix":"10.21320","volume":"9","author":[{"given":"N. S.","family":"Kulichkina","sequence":"first","affiliation":[{"name":"Scientific Research Institute of Pediatric Oncology and Hematology, N.N. Blokhin Russian Cancer Research Center, 24 Kashirskoye sh., Moscow, Russian Federation, 115478"},{"name":"\u041d\u0418\u0418 \u0434\u0435\u0442\u0441\u043a\u043e\u0439 \u043e\u043d\u043a\u043e\u043b\u043e\u0433\u0438\u0438 \u0438 \u0433\u0435\u043c\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u0438 \u0424\u0413\u0411\u0423 \u00ab\u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0438\u0439 \u043e\u043d\u043a\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u043d\u0430\u0443\u0447\u043d\u044b\u0439 \u0446\u0435\u043d\u0442\u0440 \u0438\u043c. \u041d.\u041d. \u0411\u043b\u043e\u0445\u0438\u043d\u0430\u00bb \u041c\u0438\u043d\u0437\u0434\u0440\u0430\u0432\u0430 \u0420\u043e\u0441\u0441\u0438\u0438, \u041a\u0430\u0448\u0438\u0440\u0441\u043a\u043e\u0435 \u0448., \u0434. 24, \u041c\u043e\u0441\u043a\u0432\u0430, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 115478"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. S.","family":"Belyaeva","sequence":"additional","affiliation":[{"name":"Scientific Research Institute of Pediatric Oncology and Hematology, N.N. Blokhin Russian Cancer Research Center, 24 Kashirskoye sh., Moscow, Russian Federation, 115478"},{"name":"\u041d\u0418\u0418 \u0434\u0435\u0442\u0441\u043a\u043e\u0439 \u043e\u043d\u043a\u043e\u043b\u043e\u0433\u0438\u0438 \u0438 \u0433\u0435\u043c\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u0438 \u0424\u0413\u0411\u0423 \u00ab\u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0438\u0439 \u043e\u043d\u043a\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u043d\u0430\u0443\u0447\u043d\u044b\u0439 \u0446\u0435\u043d\u0442\u0440 \u0438\u043c. \u041d.\u041d. \u0411\u043b\u043e\u0445\u0438\u043d\u0430\u00bb \u041c\u0438\u043d\u0437\u0434\u0440\u0430\u0432\u0430 \u0420\u043e\u0441\u0441\u0438\u0438, \u041a\u0430\u0448\u0438\u0440\u0441\u043a\u043e\u0435 \u0448., \u0434. 24, \u041c\u043e\u0441\u043a\u0432\u0430, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 115478"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. L.","family":"Mentkevich","sequence":"additional","affiliation":[{"name":"Scientific Research Institute of Pediatric Oncology and Hematology, N.N. Blokhin Russian Cancer Research Center, 24 Kashirskoye sh., Moscow, Russian Federation, 115478"},{"name":"\u041d\u0418\u0418 \u0434\u0435\u0442\u0441\u043a\u043e\u0439 \u043e\u043d\u043a\u043e\u043b\u043e\u0433\u0438\u0438 \u0438 \u0433\u0435\u043c\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u0438 \u0424\u0413\u0411\u0423 \u00ab\u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0438\u0439 \u043e\u043d\u043a\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u043d\u0430\u0443\u0447\u043d\u044b\u0439 \u0446\u0435\u043d\u0442\u0440 \u0438\u043c. \u041d.\u041d. \u0411\u043b\u043e\u0445\u0438\u043d\u0430\u00bb \u041c\u0438\u043d\u0437\u0434\u0440\u0430\u0432\u0430 \u0420\u043e\u0441\u0441\u0438\u0438, \u041a\u0430\u0448\u0438\u0440\u0441\u043a\u043e\u0435 \u0448., \u0434. 24, \u041c\u043e\u0441\u043a\u0432\u0430, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 115478"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. K.","family":"Boyarshinov","sequence":"additional","affiliation":[{"name":"Scientific Research Institute of Pediatric Oncology and Hematology, N.N. Blokhin Russian Cancer Research Center, 24 Kashirskoye sh., Moscow, Russian Federation, 115478"},{"name":"\u041d\u0418\u0418 \u0434\u0435\u0442\u0441\u043a\u043e\u0439 \u043e\u043d\u043a\u043e\u043b\u043e\u0433\u0438\u0438 \u0438 \u0433\u0435\u043c\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u0438 \u0424\u0413\u0411\u0423 \u00ab\u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0438\u0439 \u043e\u043d\u043a\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u043d\u0430\u0443\u0447\u043d\u044b\u0439 \u0446\u0435\u043d\u0442\u0440 \u0438\u043c. \u041d.\u041d. \u0411\u043b\u043e\u0445\u0438\u043d\u0430\u00bb \u041c\u0438\u043d\u0437\u0434\u0440\u0430\u0432\u0430 \u0420\u043e\u0441\u0441\u0438\u0438, \u041a\u0430\u0448\u0438\u0440\u0441\u043a\u043e\u0435 \u0448., \u0434. 24, \u041c\u043e\u0441\u043a\u0432\u0430, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 115478"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. S.","family":"Levashov","sequence":"additional","affiliation":[{"name":"Scientific Research Institute of Pediatric Oncology and Hematology, N.N. Blokhin Russian Cancer Research Center, 24 Kashirskoye sh., Moscow, Russian Federation, 115478"},{"name":"\u041d\u0418\u0418 \u0434\u0435\u0442\u0441\u043a\u043e\u0439 \u043e\u043d\u043a\u043e\u043b\u043e\u0433\u0438\u0438 \u0438 \u0433\u0435\u043c\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u0438 \u0424\u0413\u0411\u0423 \u00ab\u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0438\u0439 \u043e\u043d\u043a\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u043d\u0430\u0443\u0447\u043d\u044b\u0439 \u0446\u0435\u043d\u0442\u0440 \u0438\u043c. \u041d.\u041d. \u0411\u043b\u043e\u0445\u0438\u043d\u0430\u00bb \u041c\u0438\u043d\u0437\u0434\u0440\u0430\u0432\u0430 \u0420\u043e\u0441\u0441\u0438\u0438, \u041a\u0430\u0448\u0438\u0440\u0441\u043a\u043e\u0435 \u0448., \u0434. 24, \u041c\u043e\u0441\u043a\u0432\u0430, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 115478"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. V.","family":"Glekov","sequence":"additional","affiliation":[{"name":"Scientific Research Institute of Pediatric Oncology and Hematology, N.N. Blokhin Russian Cancer Research Center, 24 Kashirskoye sh., Moscow, Russian Federation, 115478"},{"name":"\u041d\u0418\u0418 \u0434\u0435\u0442\u0441\u043a\u043e\u0439 \u043e\u043d\u043a\u043e\u043b\u043e\u0433\u0438\u0438 \u0438 \u0433\u0435\u043c\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u0438 \u0424\u0413\u0411\u0423 \u00ab\u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0438\u0439 \u043e\u043d\u043a\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u043d\u0430\u0443\u0447\u043d\u044b\u0439 \u0446\u0435\u043d\u0442\u0440 \u0438\u043c. \u041d.\u041d. \u0411\u043b\u043e\u0445\u0438\u043d\u0430\u00bb \u041c\u0438\u043d\u0437\u0434\u0440\u0430\u0432\u0430 \u0420\u043e\u0441\u0441\u0438\u0438, \u041a\u0430\u0448\u0438\u0440\u0441\u043a\u043e\u0435 \u0448., \u0434. 24, \u041c\u043e\u0441\u043a\u0432\u0430, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 115478"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandr Valentinovich","family":"Popa","sequence":"additional","affiliation":[{"name":"Scientific Research Institute of Pediatric Oncology and Hematology, N.N. Blokhin Russian Cancer Research Center, 24 Kashirskoye sh., Moscow, Russian Federation, 115478"},{"name":"\u041d\u0418\u0418 \u0434\u0435\u0442\u0441\u043a\u043e\u0439 \u043e\u043d\u043a\u043e\u043b\u043e\u0433\u0438\u0438 \u0438 \u0433\u0435\u043c\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u0438 \u0424\u0413\u0411\u0423 \u00ab\u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0438\u0439 \u043e\u043d\u043a\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u043d\u0430\u0443\u0447\u043d\u044b\u0439 \u0446\u0435\u043d\u0442\u0440 \u0438\u043c. \u041d.\u041d. \u0411\u043b\u043e\u0445\u0438\u043d\u0430\u00bb \u041c\u0438\u043d\u0437\u0434\u0440\u0430\u0432\u0430 \u0420\u043e\u0441\u0441\u0438\u0438, \u041a\u0430\u0448\u0438\u0440\u0441\u043a\u043e\u0435 \u0448., \u0434. 24, \u041c\u043e\u0441\u043a\u0432\u0430, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 115478"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8834","published-online":{"date-parts":[[2016,1,1]]},"reference":[{"key":"16374","unstructured":"\u0411\u0435\u043b\u044f\u0435\u0432\u0430 \u0415.\u0421. \u0421\u043e\u0432\u0440\u0435\u043c\u0435\u043d\u043d\u044b\u0435 \u043f\u043e\u0434\u0445\u043e\u0434\u044b \u043a \u043b\u0435\u0447\u0435\u043d\u0438\u044e \u0434\u0435\u0442\u0435\u0439 \u0441 \u0440\u0430\u0441\u043f\u0440\u043e\u0441\u0442\u0440\u0430\u043d\u0435\u043d\u043d\u044b\u043c\u0438 \u0441\u0442\u0430\u0434\u0438\u044f\u043c\u0438 \u043b\u0438\u043c\u0444\u043e\u043c\u044b \u0425\u043e\u0434\u0436\u043a\u0438\u043d\u0430: \u0410\u0432\u0442\u043e\u0440\u0435\u0444. \u0434\u0438\u0441. \u2026 \u043a\u0430\u043d\u0434. \u043c\u0435\u0434. \u043d\u0430\u0443\u043a. \u041c., 2009. \u0421. 1\u201329."},{"key":"16375","unstructured":"[Belyaeva ES. Sovremennye podkhody k lecheniyu detei s rasprostranennymi stadiyami limfomy Khodzhkina. (Modern approaches to treatment of children with advanced Hodgkin\u2019s lymphoma.) [dissertation] Moscow; 2009. p. 1\u201329. (In Russ)]"},{"key":"16376","doi-asserted-by":"crossref","unstructured":"Schellong G, Dorfell W, Claviez A, et al. Salvage therapy of progressive and recurrent Hodgkin\u2019s disease: results from a multicenter study of the pediatric DAL\/GPOH-HD study group. J Clin Oncol. 2005;23:6181\u20139. doi: 10.1200\/JCO.2005.07.930.","DOI":"10.1200\/JCO.2005.07.930"},{"key":"16377","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19870601)59:11<1870::AID-CNCR2820591105>3.0.CO;2-D"},{"key":"16378","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.02.139"},{"key":"16379","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2012.09199.x"},{"key":"16380","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25225"},{"key":"16381","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.07.930"},{"key":"16382","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-200411000-00010"},{"key":"16383","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1700838"},{"key":"16384","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2010.07.002"},{"key":"16385","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.5887"},{"key":"16386","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-11-189399"},{"key":"16387","doi-asserted-by":"publisher","DOI":"10.3109\/10428190903580410"},{"key":"16388","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-2069"},{"key":"16389","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2015.1048208"}],"container-title":["Clinical Oncohematology"],"original-title":[],"link":[{"URL":"https:\/\/bloodjournal.ru\/index.php\/coh\/article\/download\/463\/428","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bloodjournal.ru\/index.php\/coh\/article\/download\/463\/428","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T11:29:34Z","timestamp":1764502174000},"score":1,"resource":{"primary":{"URL":"https:\/\/bloodjournal.ru\/index.php\/coh\/article\/view\/463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,1]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,1,1]]}},"URL":"https:\/\/doi.org\/10.21320\/2500-2139-2016-9-1-13-21","relation":{},"ISSN":["2500-2139","1997-6933"],"issn-type":[{"type":"electronic","value":"2500-2139"},{"type":"print","value":"1997-6933"}],"subject":[],"published":{"date-parts":[[2016,1,1]]}}}